Haloperidol counteracts the ketamine-induced disruption of processing negativity, but not that of the P300 amplitude

Medicin og biovidenskab

• 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol 26%
• Dopamine D2 Receptors 6%
• Haloperidol 99%
• Healthy Volunteers 7%
• Ketamine 100%
• N-Methyl-D-Aspartate Receptors 10%
• N-Methylaspartate 5%
• Placebos 59%
• Prefrontal Cortex 4%
• Schizophrenia 4%
• Task Performance and Analysis 17%
• Therapeutics 2%